LifeTech Scientific (HKSE:01302) 3-Year Revenue Growth Rate : 21.70% (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific 3-Year Revenue Growth Rate?

LifeTech Scientific's Revenue per Share for the six months ended in Jun. 2024 was HK$0.16.

During the past 12 months, LifeTech Scientific's average Revenue per Share Growth Rate was 6.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 21.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of LifeTech Scientific was 22.10% per year. The lowest was 5.00% per year. And the median was 15.60% per year.

Competitive Comparison of LifeTech Scientific's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, LifeTech Scientific's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeTech Scientific's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's 3-Year Revenue Growth Rate falls into.

LifeTech Scientific 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

LifeTech Scientific (HKSE:01302) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

LifeTech Scientific 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeTech Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

81X:Germany

Address

No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063

Website

http://www.lifetechmed.com

LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

Executives

Xie Yuehui	2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited	2101 Beneficial owner
Hhlr Advisors, Ltd.	2102 Investment manager
Bank Of Communications Trustee Limited	2301 Trustee
Xie Yuehui	2201 Interest of corporation controlled by you
Hhlr Fund, L.p.	2101 Beneficial owner
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

LifeTech Scientific Headlines

No Headlines